An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma - Archive ouverte HAL Access content directly
Journal Articles Oncotarget Year : 2016

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

(1) , (1) , , , (2) , , , (3) , (1) ,
1
2
3
T. Conroy
  • Function : Author
Françoise Desseigne
  • Function : Author
S. Gourgou-Bourgade
  • Function : Author
T. Stanbury
  • Function : Author
B. Ozenne
  • Function : Author
M. Buyse
  • Function : Author

Dates and versions

hal-02053624 , version 1 (01-03-2019)

Identifiers

Cite

Julien Péron, Pascal Roy, T. Conroy, Françoise Desseigne, M. Ychou, et al.. An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma. Oncotarget, 2016, 7, pp.82953-28960. ⟨10.18632/oncotarget.12761⟩. ⟨hal-02053624⟩
26 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More